| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 3,087 | 4,402 | ||
| Accounts receivable, net of allowance of 495 and 390, respectively | 2,134 | 1,633 | ||
| Prepaid expenses and other current assets | 565 | 695 | ||
| Total current assets | 5,786 | 6,730 | ||
| Goodwill | 8,450 | 8,450 | ||
| Gross property and equipment | 8,673 | - | ||
| Less accumulated depreciation | 3,031 | - | ||
| Property and equipment, net | 5,642 | 5,129 | ||
| Operating lease right-of-use asset | 3,383 | 3,244 | ||
| Intangible assets, net | 2,172 | 2,225 | ||
| Deposits and other | 211 | 255 | ||
| Total assets | 25,644 | 26,033 | ||
| Accounts payable | 2,103 | 1,763 | ||
| Accrued expenses | 2,682 | 2,302 | ||
| Current portion of contract liabilities | 537 | 480 | ||
| Current portion of operating lease liability | 734 | 654 | ||
| Current portion of financing lease liability | 55 | 55 | ||
| Current portion of debt | 339 | 157 | ||
| Other current liabilities | 987 | 1,015 | ||
| Total current liabilities | 7,437 | 6,426 | ||
| Contract liabilities, net of current portion | 1 | 5 | ||
| Employee retention credit liability | 2,904 | 2,904 | ||
| Operating lease liability, net of current portion | 2,866 | 2,814 | ||
| Financing lease liability, net of current portion | 125 | 141 | ||
| Debt, net of current portion | 8,379 | 7,760 | ||
| Other liabilities | 1,400 | 1,400 | ||
| Total liabilities | 23,112 | 21,450 | ||
| Common stock, 0.0001 par value per share. authorized 200,000,000 shares issued and outstanding 8,266,877 shares as of september 30, 2025 and 5,889,520 shares as of december 31, 2024 | 1 | - | ||
| Additional paid-in capital | 120,995 | 117,647 | ||
| Accumulated deficit | -118,464 | -113,064 | ||
| Total stockholders equity | 2,532 | 4,583 | ||
| Total liabilities and stockholders equity | 25,644 | 26,033 | ||
Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS)